BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Diagnosis
12 results:

  • 1. Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
    Wang Y; Dackus GMHE; Rosenberg EH; Cornelissen S; de Boo LW; Broeks A; Brugman W; Chan TWS; van Diest PJ; Hauptmann M; Ter Hoeve ND; Isaeva OI; de Jong VMT; Jóźwiak K; Kluin RJC; Kok M; Koop E; Nederlof PM; Opdam M; Schouten PC; Siesling S; van Steenis C; Voogd AC; Vreuls W; Salgado RF; Linn SC; Schmidt MK
    BMC Med; 2024 Jan; 22(1):9. PubMed ID: 38191387
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. COVID-19 mRNA Vaccine-Associated Uveitis Leading to diagnosis of Sarcoidosis: Case Report and Review of Literature.
    Matsuo T; Honda H; Tanaka T; Uraguchi K; Kawahara M; Hagiya H
    J Investig Med High Impact Case Rep; 2022; 10():23247096221086450. PubMed ID: 35313760
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?
    Grandi G; Perrone AM; Perrone A; Mandato VD; Comerci G; Sammarini M; Merisio C; Amadori A; Stefanetti M; Martinello R; Facchinetti F; De Iaco P;
    Maturitas; 2021 Jan; 143():59-64. PubMed ID: 33308637
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer.
    Van Berckelaer C; Van Geyt M; Linders S; Rypens C; Trinh XB; Tjalma WAA; Van Laere S; Colpaert C; Dirix L; van Dam PA
    Breast; 2020 Oct; 53():212-220. PubMed ID: 32890963
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression.
    Van Berckelaer C; Rypens C; van Dam P; Pouillon L; Parizel M; Schats KA; Kockx M; Tjalma WAA; Vermeulen P; van Laere S; Bertucci F; Colpaert C; Dirix L
    Breast Cancer Res; 2019 Feb; 21(1):28. PubMed ID: 30777104
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive breast cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Liu S; Chen B; Burugu S; Leung S; Gao D; Virk S; Kos Z; Parulekar WR; Shepherd L; Gelmon KA; Nielsen TO
    JAMA Oncol; 2017 Nov; 3(11):e172085. PubMed ID: 28750133
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Experiments on the Feature Selection and Classiifcation of Ultrasound Elastography Images for the diagnosis of breast cancers].
    Zhang Y; Zhang Y; Xiao Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2016 Nov; 40(6):397-402. PubMed ID: 29792411
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive breast cancer.
    Perez EA; Ballman KV; Tenner KS; Thompson EA; Badve SS; Bailey H; Baehner FL
    JAMA Oncol; 2016 Jan; 2(1):56-64. PubMed ID: 26469139
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Expression of Cox-2 and Bcl-2 in Paget's disease of the breast.
    Alikanoglu AS; Yildirim M; Suren D; Tutus B; Kaya V; Topal CS; Keser S; Karadayi AN; Kapucuoglu FN; Ayva S; Gunduz S
    Asian Pac J Cancer Prev; 2015; 16(3):1041-5. PubMed ID: 25735328
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer.
    Won HS; Kim YA; Lee JS; Jeon EK; An HJ; Sun DS; Ko YH; Kim JS
    Cancer Invest; 2013 Oct; 31(8):516-21. PubMed ID: 23902164
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.
    Scheidhauer K; Walter C; Seemann MD
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S70-9. PubMed ID: 15133634
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.
    Salgado R; Junius S; Benoy I; Van Dam P; Vermeulen P; Van Marck E; Huget P; Dirix LY
    Int J Cancer; 2003 Feb; 103(5):642-6. PubMed ID: 12494472
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.